Home
Joshua B. Cohen, Co-CEO: Amylyx Pharmaceuticals AMLX Planned sale · Filed 09/11
Trade details
- Type
- Planned sale notice
- Person
- Joshua B. CohenCo-CEO
- Planned sale date
- 26/09/10
- Filed
- 26/09/11
0.8% of shares outstanding to be sold
Amylyx Pharmaceuticals trades, last 26 weeks
What else happened in Amylyx Pharmaceuticals around then
Filed or reported within 30 days of the trade day · 08/11~10/10Joshua B. Cohen's recent trades
- Joshua B. Cohen
SellAmylyx Pharmaceuticals
SellAmylyx Pharmaceuticals
AMLX
$424K
29,282 sh
$424K
Filed 03/04
Traded 03/02
- Joshua B. Cohen
Planned saleAmylyx Pharmaceuticals
Planned saleAmylyx Pharmaceuticals
AMLX
$424.1K
29,282 sh
$424.1K
Filed 03/02
Traded 03/02
- Joshua B. Cohen
SellAmylyx Pharmaceuticals
SellAmylyx Pharmaceuticals
AMLX
$227.5K
15,500 sh
$227.5K
Filed 02/04
Traded 02/02
- Joshua B. Cohen
Planned saleAmylyx Pharmaceuticals
Planned saleAmylyx Pharmaceuticals
AMLX
$227.6K
15,500 sh
$227.6K
Filed 02/02
Traded 02/02
- Joshua B. Cohen
SellAmylyx Pharmaceuticals
SellAmylyx Pharmaceuticals
AMLX
$1.9M
136,193 sh
$1.9M
Filed 01/20
Traded 01/15